Media Coverage

15 Fastest-Growing Private Life Science Companies in the U.S.

  • Published on: August 22, 2018

Inc. magazine collates an annual list of the fastest-growing private companies in America. This year, 15 of the top 5,000 were related to healthcare, medical…

Read More

Bioasis and BioAgilytix Announce Strategic Collaboration to Advance xb3 TM-001 in Brain Cancer

  • Published on: July 11, 2018

Bioasis Technologies and testing services provider BioAgilytix will partner on the development and validation of bioanalytical methods to support and advance the xB3 -001 program,…

Read More

BioAgilytix and ATCC Present the First ‘Trends in Cell-Based Assays’ Forum

  • Published on: April 11, 2018

The first ‘Trends in Cell-Based Assays’ forum was held this week in Cambridge, hosted by ATCC and BioAgilytix, who partnered with Shire Pharmaceuticals, Takeda Pharmaceuticals,…

Read More

Clinical Relevance of Immunogenicity: an Interview with Arno Kromminga

  • Published on: March 26, 2018

Dr. Arno Kromminga is a certified specialized immunologist with over 20 years of expertise covering the entire cascade of assay strategy and characterization of immune…

Read More

Exploratory Biomarker Testing: to Qualify or Validate the Assay?

  • Published on: March 12, 2018

There is a lot of confusion in the world of biomarker testing when it comes to the terms ‘assay qualification’ and ‘assay validation’. These two…

Read More

Immunogenicity Considerations for ADCs: A Focus on Neutralizing Antibody Assays

  • Published on: December 18, 2017

Summary With increasing numbers of ADCs in clinical trials and post-marketing surveillance, more clinical data are being collected that will increase our understanding of ADCs,…

Read More

ATCC Adds Novel In Vitro Model to Expanding Portfolio

  • Published on: November 23, 2017

ATCC has released an in vitro model system for a key mechanism of invasion and metastasis in lung cancer as the company continues its efforts…

Read More

Bioanalysis Zone’s “Ask the Experts” Series on Biosimilars

  • Published on: October 17, 2017

Summary Biosimilars are subsequent versions of an innovator product and have gained popularity over the last 30 years. This series explores the role of biosimilars,…

Read More

Triangle Business Journal: Durham’s BioAgilytix heading into expansion mode

  • Published on: March 9, 2017

BioAgilytix is beefing up in Durham. The contact research organization is expanding its existing 29,000-square-foot space to roughly 50,000 square feet at 2300 Englert Drive…

Read More

Meeting the Rigorous Demands of Biosimilar Pharmacokinetics

  • Published on: January 30, 2017

Abstract Rapid growth of the market for biosimilar products is expected in the next few years, as the patents for a large number of approved…

Read More